|
CoreLab News |
 |
|
|
CoreLab Partners showcases technologies at 47th Annual DIA Meeting
Princeton, NJ June 17, 2011 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, will showcase several new technological solutions to coincide with the upcoming DIA meeting in Chicago, Illinois to be held from June 20 - 23, 2011.
“I am pleased to announce that as a part of an on-going commitment to our sponsor partners to deliver the highest possible quality through a cost effective, technologically driven process, we are positioned to launch another series of innovative and enabling solutions in both our ImagEngineSM and WebHeart® platforms”, said CoreLab Partners’ President and CEO, Dr. Mike Woehler. “Our proprietary advanced imaging application, ImagEngineSM, will perform 3D and volumetric measurements while incorporating multi-planer reconstruction tools with lesion propagation which will expand our therapeutic reach and addresses the growing needs for this type of image analysis going forward. Further, we will add a highly-automated algorithmic solution to conduct Thorough QT (TQT) studies that is fully integrated with our WebHeartSM system and complements our current suite of ECG, Holter, ABPM, and HRV/HRT services”, added Woehler.
CoreLab Partners invites you to learn more about their comprehensive suite of service capabilities and new technological solutions at booth #1035 at the 47th Annual DIA meeting in Chicago, Illinois.
About CoreLab Partners, Inc
CoreLab Partners, with offices in North America, Europe and Asia, provides comprehensive medical image assessment and cardiac safety services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with on-staff, board certified, sub-specialty trained Radiologists, Cardiologists, nuclear medicine physicians and Oncologists. CoreLab Partners delivers disciplined solutions for the collection, analysis and management of patient images and cardiac safety & efficacy information during drug development. Driven by best-in-class science, enabling technologies and service quality, CoreLabs’ is a global leader providing imaging sciences in all major modalities complemented by service offerings in the conduct of ECG, Thorough QT, Holter Monitoring, Ambulatory Blood Pressure Monitoring, HRV/HRT, Telemedicine and Pulse Wave Analysis.
|
|
|